News headlines about Agilent Technologies (NYSE:A) have trended positive recently, according to Accern Sentiment. Accern rates the sentiment of press coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Agilent Technologies earned a coverage optimism score of 0.33 on Accern’s scale. Accern also gave media stories about the medical research company an impact score of 45.0280558741265 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.
These are some of the media stories that may have effected Accern’s scoring:
Agilent Technologies (NYSE A) opened at $68.02 on Wednesday. The company has a quick ratio of 2.85, a current ratio of 3.30 and a debt-to-equity ratio of 0.37. Agilent Technologies has a 12 month low of $50.09 and a 12 month high of $75.00. The company has a market cap of $21,970.00, a P/E ratio of 32.55, a PEG ratio of 2.07 and a beta of 1.28.
Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Monday, November 20th. The medical research company reported $0.67 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.62 by $0.05. Agilent Technologies had a net margin of 15.30% and a return on equity of 16.95%. The business had revenue of $1.19 billion during the quarter, compared to analyst estimates of $1.17 billion. During the same quarter last year, the firm posted $0.59 earnings per share. The business’s revenue for the quarter was up 7.0% compared to the same quarter last year. sell-side analysts expect that Agilent Technologies will post 2.58 EPS for the current year.
A number of equities research analysts have recently commented on A shares. Zacks Investment Research upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating and set a $76.00 target price for the company in a research report on Tuesday, October 31st. Barclays restated a “buy” rating and set a $74.00 price objective on shares of Agilent Technologies in a research report on Monday, January 8th. Robert W. Baird restated a “buy” rating and set a $70.00 price objective on shares of Agilent Technologies in a research report on Friday, October 20th. Evercore ISI started coverage on shares of Agilent Technologies in a research report on Wednesday, January 3rd. They set an “outperform” rating and a $75.00 price objective for the company. Finally, ValuEngine cut shares of Agilent Technologies from a “buy” rating to a “hold” rating in a research report on Friday, December 1st. Six analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. The stock currently has an average rating of “Buy” and an average price target of $69.25.
In related news, CEO Michael R. Mcmullen sold 22,481 shares of Agilent Technologies stock in a transaction that occurred on Friday, November 17th. The shares were sold at an average price of $68.77, for a total value of $1,546,018.37. Following the completion of the transaction, the chief executive officer now owns 336,637 shares in the company, valued at $23,150,526.49. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, VP Mark Doak sold 4,154 shares of Agilent Technologies stock in a transaction that occurred on Tuesday, December 5th. The stock was sold at an average price of $67.00, for a total transaction of $278,318.00. Following the completion of the transaction, the vice president now owns 68,270 shares of the company’s stock, valued at approximately $4,574,090. The disclosure for this sale can be found here. In the last three months, insiders sold 219,991 shares of company stock valued at $15,468,795.
TRADEMARK VIOLATION NOTICE: “Agilent Technologies (NYSE:A) Earns Daily Coverage Optimism Rating of 0.33” was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this news story on another website, it was stolen and reposted in violation of U.S. and international trademark and copyright law. The legal version of this news story can be read at https://www.dispatchtribunal.com/2018/02/14/favorable-press-coverage-somewhat-unlikely-to-affect-agilent-technologies-a-share-price.html.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.